A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder

Clinical trial NCT06878833 · WITHDRAWN

Trial details

NCT number: NCT06878833
Sponsor: Lyndra Inc.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2025-04-18
Primary completion: 2026-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.